EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieKohortenstudie

Screening for potential late-onset Pompe disease patients among individuals with suspected sleep apnea: A prospective, multicenter observational Cohort Study in Japan (PSSAP-J Study)

Motoo Yamauchi iD, Ryutaro Shirahama, Satomi Shiota, Tsuguo Nishijima, Hideaki Nakayama, Yasuyoshi Ohshima, Motomichi Kosuga, Jiro Terada, Takuya Oguri, Yasuhiro Aoki, Keiko Ishigaki, Kazuma Sugie und 5 weitere

Sleep and Breathing · 2026

DOI: 10.1007/s11325-026-03796-8 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Sleep and Breathing, 2026. Verfasst von Motoo Yamauchi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathophysiology of Nursing, Nara Medical University, 88 Shijo-Cho, Kashihara, Nara, 634-8524, Japan. motoo@naramed-u.ac.jp. Hauptthemen laut MEDLINE: Glycogen Storage Disease Type II, Sleep Apnea Syndromes. Die Arbeit nennt 16 Literaturangaben. Gefördert von: Sanofi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pompe disease is an autosomal recessive disorder caused by a deficiency of acid α-glucosidase (GAA) enzyme. This deficiency induces progressive glycogen accumulation, leading to weakness of the respiratory muscle, including the diaphragm. As established enzyme replacement therapy is available for Pompe disease, earlier detection of potential Late-Onset Pompe Disease (LOPD) and subsequent intervention would have a significant clinical impact.

Purpose

Our hypothesis was that sleep problems, including sleep-disordered breathing (SDB) and clinical symptoms, may indicate an early stage of LOPD, since decreased respiratory muscle activity often presents initially during sleep. The primary aim of the PSSAP-J study was to demonstrate a higher prevalence of LOPD in a sleep-laboratory-based population. Secondary aims included identifying predictive factors for LOPD from diagnostic polysomnography (PSG) findings and clinical symptoms.

Methods

This prospective multicenter observational cohort study enrolled consecutive patients presenting to sleep laboratories for overnight PSG due to suspected SDB. All patients underwent a Dried Blood Spot (DBS) screening for GAA activity. Genetic analysis of the GAA gene was performed for confirmatory testing when indicated.

Result

A total of 724 participants were analyzed, although the COVID-19 pandemic prevented reaching the target sample size ( n = 1,500). No definitive LOPD cases were confirmed among those who completed the confirmatory testing (prevalence 0%; 95% confidence interval [CI], 0.00%–0.51%). However, seven screen-positive patients declined confirmatory testing and were classified as indeterminate cases. Consequently, we could not definitively establish a higher prevalence or identify predictive factors for LOPD in this population.

Conclusion

Although the primary study aims could not be confirmed due to the sample size shortfall and the presence of indeterminate cases, our findings highlight the importance for sleep physicians to maintain a high index of suspicion for underlying myopathies, such as LOPD, in clinical practice. Clinical trial registration UMIN000039191, UMIN Clinical Trials Registry ( http://www.umin.ac.jp/ctr ).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycogen Storage Disease Type IISleep Apnea SyndromesHumansJapanFemaleProspective StudiesMalePolysomnographyMiddle AgedAdultCohort StudiesMass ScreeningPrevalenceAged

Stichwörter der Autor:innen

HypoventilationLate-onset Pompe diseasePompe diseasePrevalenceRespiratory physiologySleep disordered breathing

Autor:innen und Institutionen

  • Department of Clinical Pathophysiology of Nursing, Nara Medical University, 88 Shijo-Cho, Kashihara, Nara, 634-8524, Japan. motoo@naramed-u.ac.jp.
  • Department of Respiratory Medicine, Nara Medical University, Nara, Japan. motoo@naramed-u.ac.jp.
  • RESM Respiratory and Sleep Medical-Care Clinic, Yokohama, Japan.
  • Division of Respiratory Medicine, Juntendo University Faculty of Medicine & Graduate School of Medicine, Tokyo, Japan.
  • Division of Behavioral Sleep Medicine, Iwate Medical University School of Medicine, Morioka, Japan.
  • Department of Somnology, Tokyo Medical University, Tokyo, Japan.

ORCID-Profile: Motoo Yamauchi

Förderung

  • Sanofi

Zitieren

APA

Yamauchi, M., Shirahama, R., Shiota, S., Nishijima, T., Nakayama, H., Ohshima, Y., Kosuga, M., Terada, J., Oguri, T., Aoki, Y., Ishigaki, K., Sugie, K., Yagi, T., Muraki, H., Fujita, Y., Takatani, T., & Muro, S. (2026). Screening for potential late-onset Pompe disease patients among individuals with suspected sleep apnea: A prospective, multicenter observational Cohort Study in Japan (PSSAP-J Study). Sleep and Breathing. https://doi.org/10.1007/s11325-026-03796-8

Vancouver

Yamauchi M, Shirahama R, Shiota S, Nishijima T, Nakayama H, Ohshima Y, et al. Screening for potential late-onset Pompe disease patients among individuals with suspected sleep apnea: A prospective, multicenter observational Cohort Study in Japan (PSSAP-J Study). Sleep and Breathing. 2026. doi:10.1007/s11325-026-03796-8

BibTeX
@article{Yamauchi2026,
  author = {Yamauchi, Motoo and Shirahama, Ryutaro and Shiota, Satomi and Nishijima, Tsuguo and Nakayama, Hideaki and Ohshima, Yasuyoshi and Kosuga, Motomichi and Terada, Jiro and Oguri, Takuya and Aoki, Yasuhiro and Ishigaki, Keiko and Sugie, Kazuma and Yagi, Tomoko and Muraki, Hisae and Fujita, Yukio and Takatani, Tsunenori and Muro, Shigeo},
  title = {Screening for potential late-onset Pompe disease patients among individuals with suspected sleep apnea: A prospective, multicenter observational Cohort Study in Japan (PSSAP-J Study)},
  journal = {Sleep and Breathing},
  year = {2026},
  doi = {10.1007/s11325-026-03796-8}
}
Kostenlos starten →